Related Experiment Video
Updated: Aug 14, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO
Gerhard Wingender1, Natalio Garbi, Beatrix Schumak
1Institut für Molekulare Medizin und Experimentelle Immunologie, Bonn, Germany.
Abstract:
CpG-rich oligonucleotides (CpG-ODN) bind to Toll-like receptor 9 (TLR9) and are used as powerful adjuvants for vaccination. Here we report that CpG-ODN not only act as immune stimulatory agents but can also induce strong immune suppression depending on the anatomical location of application. In agreement with the adjuvant effect, subcutaneous application of antigen plus CpG-ODN resulted in antigen-specific T cell activation in local lymph nodes. In contrast, systemic application of CpG-ODN resulted in suppression of T cell expansion and CTL activity in the spleen. The suppressive effect was mediated by indoleamine 2,3-dioxygenase (IDO) as indicated by the observation that CpG-ODN induced IDO in the spleen and that T cell suppression could be abrogated by 1-methyl-tryptophan (1-MT), an inhibitor of IDO. No expression of IDO was observed in lymph nodes after injection of CpG-ODN, explaining why suppression was restricted to the spleen. Studies with a set of knockout mice demonstrated that the CpG-ODN-induced immune suppression is dependent on TLR9 stimulation and independent of type I and type II interferons. The present study shows that for the use of CpG-ODN as an adjuvant in vaccines, the route of application is crucial and needs to be considered. In addition, the results indicate that down-modulation of immune responses by CpG-ODN may be possible in certain pathological conditions.
Insights
CpG oligonucleotides (CpG-ODN) can stimulate or suppress immune responses. Application site determines the effect: subcutaneous boosts immunity, while systemic application suppresses T cell activity via indoleamine 2,3-dioxygenase (IDO).
Area of Science:
- Immunology
- Vaccinology
Background:
- CpG-rich oligonucleotides (CpG-ODN) are known Toll-like receptor 9 (TLR9) agonists used as vaccine adjuvants.
- Their immune-modulating effects are typically considered stimulatory.
Purpose of the Study:
- To investigate the dual role of CpG-ODN as immune stimulators and suppressors.
- To determine the influence of anatomical application site on CpG-ODN's immune effects.
- To elucidate the mechanism underlying CpG-ODN-induced immune suppression.
Main Methods:
- Administered antigen plus CpG-ODN subcutaneously and systemically in mice.
- Assessed antigen-specific T cell activation in lymph nodes and spleen.
- Measured CTL activity.
- Investigated the role of indoleamine 2,3-dioxygenase (IDO) using 1-methyl-tryptophan (1-MT).
- Utilized knockout mice lacking TLR9, type I, and type II interferons.
Main Results:
- Subcutaneous application of CpG-ODN with antigen led to T cell activation in local lymph nodes.
- Systemic application of CpG-ODN resulted in suppressed T cell expansion and CTL activity in the spleen.
- CpG-ODN induced IDO expression in the spleen, and 1-MT abrogated the T cell suppression.
- IDO expression was not observed in lymph nodes.
- CpG-ODN-induced suppression was TLR9-dependent but independent of type I and II interferons.
Conclusions:
- The route of administration is critical for the immune outcome of CpG-ODN application.
- Systemic CpG-ODN can induce immune suppression mediated by IDO, primarily in the spleen.
- CpG-ODN's potential for immune suppression could be harnessed for treating certain pathological conditions.
More Related Videos
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Abnormal Proliferation
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inhibition of Cdk Activity
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

